Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, says Aetna engages consumers in decision-making in a variety of ways.
Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, says Aetna engages consumers in decision-making in a variety of ways. The insurer provides tools for the employed population, which include virtual people and other digital programs about benefit designs. They also offer tools for the general population, which include iTriage to help them find a provider or facility. All of the health plan’s tools increase consumers’ access and allow them to compare costs.
“For patients who are in the exchanges, both the public and the private exchanges, [these tools] help them to make decisions about what kind of benefit will work for them in their point of life,” Dr Pezalla says. “There’s a lot of things that can help them to choose a plan—and it’s not just a matter of cost or choosing just on ‘I’ve heard of that doctor and hospital’—but choosing a plan that will work for them, both in terms of their medical situation and their financial situation.”
)
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer
March 28th 2024This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.
Read More
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More